BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8813605)

  • 1. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors.
    Lione LA; Nutt DJ; Hudson AL
    Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R; Olmos G; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
    Lione LA; Nutt DJ; Hudson AL
    Eur J Pharmacol; 1998 Jul; 353(1):123-35. PubMed ID: 9721049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.
    Wiest SA; Steinberg MI
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
    Wiest SA; Steinberg MI
    Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain.
    Robinson ES; Tyacke RJ; Nutt DJ; Hudson AL
    Eur J Pharmacol; 2002 Aug; 450(1):55-60. PubMed ID: 12176109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex.
    Callado LF; Maeztu AI; Ballesteros J; Gutiérrez M; Meana JJ
    Eur J Pharmacol; 2001 Jul; 423(2-3):109-14. PubMed ID: 11448473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
    MacInnes N; Handley SL
    Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
    MacKinnon AC; Redfern WS; Brown CM
    Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
    Olmos G; Alemany R; Boronat MA; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ligands selective for central I2-imidazoline binding sites.
    Hudson AL; Chapleo CB; Lewis JW; Husbands S; Grivas K; Mallard NJ; Nutt DJ
    Neurochem Int; 1997 Jan; 30(1):47-53. PubMed ID: 9116587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.